Venous Thrombosis

Blood clot which forms in a vein

Aetiology

Thrombosis is considered to arise from the interplay between the three factors that make up Virchow’s triad:

Hypercoagulable state

  • Malignancy
  • Pregnancy and peripartum
  • Oestrogen therapy
  • IBD
  • Sepsis
  • Thrombophilia

Endothelial injury

  • Venous disorders
  • Venous valvular damage (e.g. from previous DVT/PE - very strong RF)
  • Trauma or surgery
  • Indwelling catheters

Circulatory stasis

  • Left ventricular dysfunction
  • Immobility or paralysis
  • Venous insufficiency/varicose veins
  • Venous obstruction - tumour, obesity, pregnancy

Pathophysiology

  • Low pressure system, platelets not activated → activates coagulation cascade → clot rich in fibrin

Formation of DVTs

  • DVTs form predominantly in the venous valve pockets and other sites of assumed stasis
  • Distal vein thrombosis: refers to DVT of the calves
  • Proximal vein thrombosis: DVT of the popliteal or femoral vein, more likely to embolise

Pulmonary embolism

  • Usually the result of a DVT (95%)
  • Can also be caused by embolism of a blood clot from the atria in a patient with AF - ARTERIAL THROMBOSIS NOT VENOUS

Clinical presentation

Deep vein thrombosis

  • Limb feels hot, swollen, tender, erythema (unilateral)
  • Pitting oedema
  • Mild fever
notion image

Pulmonay emobolism

  • Dyspnoea - often acute onset
  • Pleuritic chest pain
  • Symptoms of DVT - leg pain, swelling etc.
  • Collapse (/sudden death)
  • Fever
  • Haemoptysis
  • Tachycardia
  • Hypoxia
  • Cyanosis
  • Low BP

Investigations

DVT

  • D-dimer - rule out test for patients considered unlikely to have a DVT based on the Wells score
  • US Doppler leg scan is diagnostic - indicated if patient has raised D-dimers, or if they have a high Wells score (in which case US would be first line)

PE

  • If Wells score indicates a PE is likely - perform a CTPA
  • If Wells score indicates a PE is unlikely - perform D-dimer and if positive perform a CTPA
  • A V/Q scan is an alternative to a CTPA used in patients with renal impairment, contrast allergy or at risk from radiation where a CTPA is unsuitable
    • Try to avoid using CTPA for pregnant women (use USS or V/Q), however if patient is very unwell CTPA is the best modality so accept risk of radiation
  • Other imaging:
    • CXR - will be normal early on in PE (before infarction), often used to rule out other causes, ‘wedge-shaped infarct’ indicates PE
    • USS leg - if radiation to be avoided or DVT suspected
  • Other tests:
    • ECG - sinus tachycardia, S1Q3T3 (right heart strain pattern)
    • Troponin - may be raised due to strain on right ventricle, raised troponin is associated with worse outcomes
    • ABG - type I resp failure, respiratory alkalosis
    • Investigate underlying cause - USS, cancer screen, autoantibodies (SLE), thrombophilia screen

Management

Acute management

  • The initial management for a suspected or confirmed DVT or PE is with anticoagulation
  • Apixaban or rivaroxaban (DOACs) first line in the majority of patients
    • May be outpatient if patient considered low-risk
    • If neither apixaban or rivaroxaban are suitable then either LMWH followed by dabigatran or edoxaban OR LMWH followed by a vitamin K antagonist (VKA, i.e. warfarin)
  • Thrombolysis is recommended as the first-line treatment for massive PE where there is circulatory failure (e.g. hypotension)

Secondary prevention

  • The options for long term anticoagulation are warfarin, a DOAC or LMWH
    • Warfarin first line in antiphospholipid syndrome
    • LMWH first line in pregnancy
  • Treatment with a should be continued for at least three months
    • Provoked DVT with reversible factors - 3 months
    • Provoked DVT with irreversible factors, or unprovoked DVT - 3-6 months, potentially life-long depending on patient factors (e.g. genetic clotting disorder)
    •